TORONTO (S&P Global Ratings) Jan. 18, 2022--S&P Global Ratings today assigned its 'BB' issue-level rating and '1' recovery rating to Bausch Health Cos. Inc.'s proposed $975 million revolving credit facility and $2.5 billion senior secured term loan. The '1' recovery rating indicates our expectation for very high (90%-100%; rounded estimate: 95%) recovery in the event of a payment default. The company plans to use the proceeds from this offering, a follow-on $1 billion secured debt offering, and the proceeds from the Bausch + Lomb IPO and related debt financing (which we expect will close in early February) to fully redeem its 6.125% senior notes due 2025, refinance all of its existing term loan B facilities, partially redeem its 9.000% senior